Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: A prospective comparative study

Obesity Surgery

Volumn 16, Issue 6, 2006, Pages 752-758

  Stratis, Christos ^a   Alexandrides, Theodore ^a   Vagenas, Kostas ^a   Kalfarentzos, Fotis ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Biliopancreatic diversion; Gastric bypass; Ghrelin; Morbid obesity; Peptide YY; Roux en Y

Indexed keywords

GHRELIN; PEPTIDE YY;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; BLOOD ANALYSIS; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; LARGE INTESTINE CANCER; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS;

ADULT; APPETITE; BILIOPANCREATIC DIVERSION; COLECTOMY; COLONIC NEOPLASMS; FEMALE; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PEPTIDE HORMONES; PEPTIDE YY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; RECTAL NEOPLASMS;

EID: 33745045295     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206777346772     Document Type: Article

References (30)

1. Taubes G. As obesity rates rise, experts struggle to explain why. Science 1998; 280: 1367-8.
2. Flegal KM, Caroll MD, Ogden CL et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-7.
3. Ayyad C, Andersen T. Long-term efficiency of dietary treatment of obesity: a systematic revision of studies published between 1931 and 1999. Obes Rev 2000; 1: 113-9.
4. Drenick EJ, Johnson D. Weight reduction by fasting and semi starvation in morbid obesity: long-term follow-up. Int J Obes 1978; 2: 123-32.
5. Colquitt J, Clegg A, Sidhu M, et al. Surgery for morbid obesity. Cochrane Database Syst Rev 2003; CD003641.
6. Kalfarentzos F, Skroubis G, Kehagias I et al. A prospective comparison of vertical banded gastroplasty and Roux-en-Y gastric bypass in a non-superobese population. Obes Surg 2006; 16: 151-8.
7. Cummings DE, Shannon MH. Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 2003; 88: 2999-3002.
8. Mason EE, Doherty C, Maher JW et al. Superobesity and gastric restriction procedures. Gastroenterol Clin North Am 1987; 6: 495-502.
9. MacLean LD, Rhode BM, Nohr CW. Late outcome of isolated gastric bypass. Ann Surg 2000; 231: 524-8.
10. Kalfarentzos F, Papadoulas S, Skroubis G et al. Prospective evaluation of biliopancreatic diversion with Roux-en-Y gastric bypass in the super obese. J Gastrointest Surg 2004; 8: 479-88.
11. Brolin RE, LaMarca LB, Kenler HA et al. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg 2002; 6: 195-203.
12. Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity. J Gastrointest Surg 1997; 1: 517-25.
13. Kojima M, Hosoda H, Date Y et al. Ghrelin is a growth-hormone-releasing peptide from stomach. Nature 1999; 402: 656-60.
14. Date Y, Kojima M, Hosoda H et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-61.
15. Cummings DE, Weigle DS, Frayo RS et al. Human plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-30.
16. Holdstock C, Engstrom BE, Ohrvall M et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003; 88: 3177-83.
17. Frühbeck G, Diez-Cabellero A, Gil MJ et al. The decrease in plasma ghrelin concentration following bariatric surgery depends on the functional integrity of the fundus. Obes Surg 2004; 14: 606-12.
18. Faraj M, Havel PJ, Phelis S et al. Plasma acylationstimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003; 88: 1594-1602.
19. Batterham RL, Cowley MA, Small CJ et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 2002; 418: 650-4.
20. Korner J, Bessler M, Citilo LJ et al. Effects of Rouxen-Y gastric bypass surgery on fasting postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005; 90: 359-65.
21. Skroubis G, Anesidis S, Kehagias I et al. Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population: prospective comparison of the efficacy and the incidence of metabolic deficiencies. Obes Surg 2006; 16: 488-95.
22. English PJ, Ghatei MA, Malik IA et al. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metabol 2002; 87: 2984.
23. Batterham RL, Cohen MA, Ellis SM et al. Inhibition of food intake in obese subjects by peptide YY 3-36. N Engl J Med 2003; 349: 941-8.
24. Bartolome MA, Borque M, Martinez-Sarmiento J et al. Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty. Obes Surg 2002; 12: 324-327.
25. Adami GF, Cordera R, Marinari G et al. Plasma ghrelin concentration in the short-term following biliopancreatic diversion. Obes Surg 2003; 13: 889-92.
26. Stoeckli R, Chanda R, Langer I et al. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 2004; 12: 346-50.
27. Batterham RL, Cowley MA, Small CJ et al. Gut hormone PYY (3-36) physiologically inhibits food intake. Nature 2002; 418: 650-4.
28. Small JC, Bloom RS. Gut hormones and the control of appetite. Trends Endocrinol Metab 2004; 15: 259-63.
29. LeRoux CW, Aylwin SJB, Batterham RL et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss and improved metabolic parameters. Ann Surg 2006; 243: 108-14.
30. Borg CM, LeRoux CW, Ghatei MA et al. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006; 93: 210-5.